Full View

Hemostatic efficacy and anti-FXa (factor Xa) reversal with andexanet alfa in intracranial hemorrhage: ANNEXA-4 substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …
被引用次数：51 相关文章
[PDF] ru.nl

[PDF][PDF] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - 2021 - repository.ubn.ru.nl
BACKGROUND AND PURPOSE: Andexanet alfa is a recombinant modified human FXa
(factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and …

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal with Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova… - …, 2021 - researchinformation.amsterdamumc …
Background and Purpose: Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - europepmc.org
Background and purpose Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …
[PDF] focusonemergencymedicine.com

[PDF][PDF] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage

AM Demchuk, P Yue, E Zotova, J Nakamya… - …, 2021 - focusonemergencymedicine.com
BACKGROUND AND PURPOSE: Andexanet alfa is a recombinant modified human FXa
(factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and …

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - ingentaconnect.com
Background and Purpose: Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …
[HTML] nih.gov

[HTML][HTML] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - ncbi.nlm.nih.gov
BACKGROUND AND PURPOSE: Andexanet alfa is a recombinant modified human FXa
(factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and …

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - pubmed.ncbi.nlm.nih.gov
Background and purpose Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - Am Heart Assoc
BACKGROUND AND PURPOSE: Andexanet alfa is a recombinant modified human FXa
(factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and …
[HTML] lww.com

[HTML][HTML] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu… - Stroke, 2021 - journals.lww.com
Background and Purpose: Andexanet alfa is a recombinant modified human FXa (factor Xa)
developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of …